All stock lists
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
4.53
Insider Score
––Not scored
CNSP Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CNSP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 1.87 K | -2.90 K | 697.00 | 1.10 K | 1.10 K |
| Gross Profit | 0.00 | -1.87 K | 2.90 K | -697.00 | -1.10 K | -1.10 K |
| SG&A Expense | 1.50 M | 1.43 M | 2.82 M | 1.06 M | 1.24 M | 1.09 M |
| R&D Expense | 1.20 M | 3.54 M | 3.17 M | 2.20 M | 1.17 M | 3.24 M |
| Operating Expenses | 2.70 M | 4.97 M | 5.99 M | 3.25 M | 2.41 M | 4.34 M |
| Operating Income | -2.70 M | -4.98 M | -5.99 M | -3.25 M | -2.41 M | -4.34 M |
| Pretax Income | -2.59 M | -4.94 M | -5.96 M | -3.22 M | -2.37 M | -4.30 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.59 M | -4.94 M | -5.96 M | -3.22 M | -2.37 M | -4.30 M |
| EPS (Basic) | -0.38 | -7.30 | -10.15 | -5.76 | -6.42 | -18.93 |
| EPS (Diluted) | -0.38 | -7.30 | -10.15 | -5.76 | -6.42 | -18.93 |
| Shares Outstanding | 6.84 M | 676.17 K | 443.37 K | 558.87 K | 370.13 K | 227.22 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.